ext Oure MAY 2023 Treating Cancer by Restoring Immune Function Forward-Looking Statements 2 DIFFERENTIATED PIPELINE Multiple clinical programs, novel targets and diverse indications CAPITAL EFFICIENCY $145.5M balance sheet, runway into mid-2025 QUALITY PRODUCT DEVELOPMENT Fully integrated operations drive innovation, internal manufacturing and capital efficiency the extent that statements contained in this presentation are not descriptions of historical facts, they may be deemed to be forward-looking statem ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-38905 NextCure, Inc. (Exact name of registrant as specified in its charter) Delaware 47-5231247 (State or o ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-38905 NextCure, Inc. (Exact name of registrant as specified in its charter) Delaware 47-5231247 (State or other ...

Next@ure Next Generation Immunomedicines November 2022 Forward-Looking Statements To the extent that statements contained in this presentation are not descriptions of historical facts, they may be deemed to be forward- looking statements under the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations, forecasts, assumptions and other information available to NextCure as of the date hereof. Forward-looking statements regarding NextCure's expectations, beliefs, i ...

Next@ure Next Generation Immunomedicines August 2022 Forward-Looking Statements To the extent that statements contained in this presentation are not descriptions of historical facts, they may be deemed to be forwardlooking statements under the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations, forecasts, assumptions and other information available to NextCure as of the date hereof. Forward-looking statements include statements regarding NextCure's expectati ...

Next@ure Next Generation Immunomedicines June 2022 Forward-Looking Statements To the extent that statements contained in this presentation are not descriptions of historical facts, they may be deemed to be forwardlooking statements under the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations, forecasts, assumptions and other information available to NextCure as of the date hereof. Forward-looking statements include statements regarding NextCure's expectation ...

Next@ure Next Generation Immunomedicines 11th Annual SVB Leerink Global Healthcare Conference February 16, 2022 Forward-Looking Statements To the extent that statements contained in this presentation are not descriptions of historical facts, they may be deemed to be forward- looking statements under the Private Securities Litigation Reform Act of 1995. Words such as "may, ""will,""expect," "anticipate," "estimate," "intend," "next," "near-term," "future" and similar expressions, as well as other words and e ...

SEPTEMBER 13, 2021 Next@ure Next-Generation Immunomedicines H .C. Wainwright 23rd Annual Global Investment Conference To the extent that statements contained in this presentation are not descriptions of historical facts, they may be deemed to be forward-looking statements under the Private Securities Litigation Reform Act of 1995. Words such as "may," "will," "expect," "anticipate," "estimate," "intend," "next," "near-term," "future" and similar expressions, as well as other words and expressions referencin ...

SEPTEMBER 9, 2021 Next@ure Next-Generation Immunomedicines MORGAN STANLEY 19™ ANNUAL GLOBAL HEALTHCARE CONFERENCE Forward-Looking Statements To the extent that statements contained in this presentation are not descriptions of historical facts, they may be deemed to be forward-looking statements under the Private Securities Litigation Reform Act of 1995. Words such as "may," "will," "expect," "anticipate," "intend," " "near-term," "future" and similar expressions, as well as other words and expressions refer ...

MAY 5, 2021 Next@ure Next-Generation Immunomedicines 7th Annual Truist Securities Life Sciences Summit Forward-Looking Statements To the extent that statements contained in this presentation are not descriptions of historical facts, they may be deemed to be forward-looking statements under the Private Securities Litigation Reform Act of 1995. Words such as "may," "will," "expect," "anticipate," "intend," " "near-term," "future" and similar expressions, as well as other words and expressions referencing futu ...